Honokiol inhibits hypoxia-inducible factor-1 pathway. (Q45903004)

17 December 2017

title

Honokiol inhibits hypoxia-inducible factor-1 pathway. (English)

1 reference

17 December 2017

1 reference

Keng-Li Lan

1

1 reference

17 December 2017

Keng-Hsin Lan

2

1 reference

17 December 2017

Meei-Ling Sheu

3

1 reference

17 December 2017

Ming-Yuan Chen

4

1 reference

17 December 2017

Yi-Sheng Shih

5

1 reference

17 December 2017

Fu-Chih Hsu

6

1 reference

17 December 2017

Hong-Ming Wang

7

1 reference

17 December 2017

Ren-Shyan Liu

8

1 reference

17 December 2017

Sang-Hue Yen

9

1 reference

17 December 2017

publication date

7 April 2011

1 reference

17 December 2017

International Journal of Radiation Biology

published in

1 reference

17 December 2017

volume

87

1 reference

17 December 2017

issue

6

1 reference

17 December 2017

page(s)

579-590

1 reference

17 December 2017

Honokiol, a small molecular weight natural product, inhibits angiogenesis in vitro and tumor growth in vivo

cites work

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2011.568572

GL331 inhibits HIF-1alpha expression in a lung cancer model

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2011.568572

Honokiol: a potent chemotherapy candidate for human colorectal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2011.568572

Honokiol-mediated inhibition of PI3K/mTOR pathway: a potential strategy to overcome immunoresistance in glioma, breast, and prostate carcinoma without impacting T cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2011.568572

Cycling hypoxia and free radicals regulate angiogenesis and radiotherapy response

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2011.568572

Noninvasive assessment of tumor cell proliferation in animal models

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2011.568572

HIF-1 as a target for drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2011.568572

Honokiol, a constituent of oriental medicinal herb magnolia officinalis, inhibits growth of PC-3 xenografts in vivo in association with apoptosis induction

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2011.568572

Echinomycin, a small-molecule inhibitor of hypoxia-inducible factor-1 DNA-binding activity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2011.568572

Honokiol inhibits epidermal growth factor receptor signaling and enhances the antitumor effects of epidermal growth factor receptor inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2011.568572

mTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2011.568572

Radiation activates HIF-1 to regulate vascular radiosensitivity in tumors: role of reoxygenation, free radicals, and stress granules

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2011.568572

Inhibitory effect of magnolol and honokiol from Magnolia obovata on human fibrosarcoma HT-1080. Invasiveness in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2011.568572

Hsp90 inhibitors as novel cancer chemotherapeutic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2011.568572

Human tissue in target identification and drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2011.568572

Down-regulation of c-Src/EGFR-mediated signaling activation is involved in the honokiol-induced cell cycle arrest and apoptosis in MDA-MB-231 human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2011.568572

The role of hypoxia-inducible factors in tumorigenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2011.568572

Topoisomerase I-mediated inhibition of hypoxia-inducible factor 1: mechanism and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2011.568572

Targeting HIF-1 for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2011.568572

Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2011.568572

Honokiol, a natural plant product, inhibits the bone metastatic growth of human prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2011.568572

Increasing sensitivity to radiotherapy and chemotherapy by using novel biological agents that alter the tumor microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2011.568572

MAPK and Akt act cooperatively but independently on hypoxia inducible factor-1alpha in rasV12 upregulation of VEGF.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2011.568572

Visualizing the kinetics of tumor-cell clearance in living animals

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2011.568572

Pharmacokinetics of honokiol after intravenous administration in rats assessed using high-performance liquid chromatography

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2011.568572

Honokiol inhibits TNF-alpha-stimulated NF-kappaB activation and NF-kappaB-regulated gene expression through suppression of IKK activation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2011.568572

A novel benzimidazole analogue inhibits the hypoxia-inducible factor (HIF)-1 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2011.568572

Down-regulation of P-glycoprotein expression in MDR breast cancer cell MCF-7/ADR by honokiol

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2011.568572

Down-modulation of Bcl-XL, release of cytochrome c and sequential activation of caspases during honokiol-induced apoptosis in human squamous lung cancer CH27 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2011.568572

NS398 reduces hypoxia-inducible factor (HIF)-1alpha and HIF-1 activity: multiple-level effects involving cyclooxygenase-2 dependent and independent mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09553002.2011.568572

10.3109/09553002.2011.568572

21 January 2018

Identifiers

DOI

1 reference

17 December 2017

PubMed ID

21473672

1 reference

17 December 2017